View in EDS

Author Correction: Safety and efficacy of anti-tau monoclonal antibody gosuranemab in progressive supranuclear palsy: a phase 2, randomized, placebo-controlled trial.

Saved in:
Bibliographic Details
Title: Author Correction: Safety and efficacy of anti-tau monoclonal antibody gosuranemab in progressive supranuclear palsy: a phase 2, randomized, placebo-controlled trial.
Authors: Dam T; Biogen, Cambridge, MA, USA. tien.dam@biogen.com., Boxer AL; Memory and Aging Center, Department of Neurology, University of California, San Francisco, CA, USA., Golbe LI; Rutgers Robert Wood Johnson Medical School, New Brunswick, NJ, USA., Höglinger GU; Department of Neurology, Technische Universität München, Munich, Germany.; German Center for Neurodegenerative Diseases, Munich, Germany.; Department of Neurology, Hanover Medical School, Hanover, Germany., Morris HR; National Hospital for Neurology and Neurosurgery, London, UK., Litvan I; University of California, Parkinson and Other Movement Disorders Center, San Diego, CA, USA., Lang AE; Edmond J. Safra Program in Parkinson's Disease and the Rossy PSP Centre, Toronto Western Hospital and the University of Toronto, Toronto, Ontario, Canada., Corvol JC; Sorbonne Université, Assistance Publique Hôpitaux de Paris, INSERM, CNRS, Institut du Cerveau - Paris Brain Institute - ICM, Hôpital Pitié-Salpêtrière, Paris, France., Aiba I; Department of Neurology, National Hospital Organization Higashinagoya National Hospital, Nagoya, Japan., Grundman M; University of California, Parkinson and Other Movement Disorders Center, San Diego, CA, USA.; Global R&D Partners, LLC, San Diego, CA, USA., Yang L; Biogen, Cambridge, MA, USA., Tidemann-Miller B; Biogen, Cambridge, MA, USA., Kupferman J; Biogen, Cambridge, MA, USA., Harper K; Biogen, Cambridge, MA, USA., Kamisoglu K; Biogen, Cambridge, MA, USA., Wald MJ; Biogen, Cambridge, MA, USA., Graham DL; Biogen, Cambridge, MA, USA., Gedney L; Biogen, Cambridge, MA, USA., O'Gorman J; Biogen, Cambridge, MA, USA., Haeberlein SB; Biogen, Cambridge, MA, USA.
Corporate Authors: PASSPORT Study Group
Source: Nature medicine [Nat Med] 2023 Nov; Vol. 29 (11), pp. 2955-2956.
Publication Type: Published Erratum
Journal Info: Publisher: Nature Publishing Company Country of Publication: United States NLM ID: 9502015 Publication Model: Print Cited Medium: Internet ISSN: 1546-170X (Electronic) Linking ISSN: 10788956 NLM ISO Abbreviation: Nat Med Subsets: MEDLINE; PubMed not MEDLINE
Database: MEDLINE Ultimate
FullText Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 36253611
AccessLevel: 2
PubTypeId: unknown
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Author Correction: Safety and efficacy of anti-tau monoclonal antibody gosuranemab in progressive supranuclear palsy: a phase 2, randomized, placebo-controlled trial.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Dam+T%22">Dam T</searchLink>; Biogen, Cambridge, MA, USA. tien.dam@biogen.com.<br /><searchLink fieldCode="AU" term="%22Boxer+AL%22">Boxer AL</searchLink>; Memory and Aging Center, Department of Neurology, University of California, San Francisco, CA, USA.<br /><searchLink fieldCode="AU" term="%22Golbe+LI%22">Golbe LI</searchLink>; Rutgers Robert Wood Johnson Medical School, New Brunswick, NJ, USA.<br /><searchLink fieldCode="AU" term="%22Höglinger+GU%22">Höglinger GU</searchLink>; Department of Neurology, Technische Universität München, Munich, Germany.; German Center for Neurodegenerative Diseases, Munich, Germany.; Department of Neurology, Hanover Medical School, Hanover, Germany.<br /><searchLink fieldCode="AU" term="%22Morris+HR%22">Morris HR</searchLink>; National Hospital for Neurology and Neurosurgery, London, UK.<br /><searchLink fieldCode="AU" term="%22Litvan+I%22">Litvan I</searchLink>; University of California, Parkinson and Other Movement Disorders Center, San Diego, CA, USA.<br /><searchLink fieldCode="AU" term="%22Lang+AE%22">Lang AE</searchLink>; Edmond J. Safra Program in Parkinson's Disease and the Rossy PSP Centre, Toronto Western Hospital and the University of Toronto, Toronto, Ontario, Canada.<br /><searchLink fieldCode="AU" term="%22Corvol+JC%22">Corvol JC</searchLink>; Sorbonne Université, Assistance Publique Hôpitaux de Paris, INSERM, CNRS, Institut du Cerveau - Paris Brain Institute - ICM, Hôpital Pitié-Salpêtrière, Paris, France.<br /><searchLink fieldCode="AU" term="%22Aiba+I%22">Aiba I</searchLink>; Department of Neurology, National Hospital Organization Higashinagoya National Hospital, Nagoya, Japan.<br /><searchLink fieldCode="AU" term="%22Grundman+M%22">Grundman M</searchLink>; University of California, Parkinson and Other Movement Disorders Center, San Diego, CA, USA.; Global R&D Partners, LLC, San Diego, CA, USA.<br /><searchLink fieldCode="AU" term="%22Yang+L%22">Yang L</searchLink>; Biogen, Cambridge, MA, USA.<br /><searchLink fieldCode="AU" term="%22Tidemann-Miller+B%22">Tidemann-Miller B</searchLink>; Biogen, Cambridge, MA, USA.<br /><searchLink fieldCode="AU" term="%22Kupferman+J%22">Kupferman J</searchLink>; Biogen, Cambridge, MA, USA.<br /><searchLink fieldCode="AU" term="%22Harper+K%22">Harper K</searchLink>; Biogen, Cambridge, MA, USA.<br /><searchLink fieldCode="AU" term="%22Kamisoglu+K%22">Kamisoglu K</searchLink>; Biogen, Cambridge, MA, USA.<br /><searchLink fieldCode="AU" term="%22Wald+MJ%22">Wald MJ</searchLink>; Biogen, Cambridge, MA, USA.<br /><searchLink fieldCode="AU" term="%22Graham+DL%22">Graham DL</searchLink>; Biogen, Cambridge, MA, USA.<br /><searchLink fieldCode="AU" term="%22Gedney+L%22">Gedney L</searchLink>; Biogen, Cambridge, MA, USA.<br /><searchLink fieldCode="AU" term="%22O'Gorman+J%22">O'Gorman J</searchLink>; Biogen, Cambridge, MA, USA.<br /><searchLink fieldCode="AU" term="%22Haeberlein+SB%22">Haeberlein SB</searchLink>; Biogen, Cambridge, MA, USA.
– Name: AuthorCorporate
  Label: Corporate Authors
  Group: Au
  Data: <searchLink fieldCode="CA" term="%22PASSPORT+Study+Group%22">PASSPORT Study Group</searchLink>
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%229502015%22">Nature medicine</searchLink> [Nat Med] 2023 Nov; Vol. 29 (11), pp. 2955-2956.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Published Erratum
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Nature+Publishing+Company%22">Nature Publishing Company </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>9502015 <i>Publication Model: </i>Print <i>Cited Medium: </i>Internet <i>ISSN: </i>1546-170X (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2210788956%22">10788956 </searchLink><i>NLM ISO Abbreviation: </i>Nat Med <i>Subsets: </i>MEDLINE; PubMed not MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=36253611
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1038/s41591-022-02076-8
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 2955
    Titles:
      – TitleFull: Author Correction: Safety and efficacy of anti-tau monoclonal antibody gosuranemab in progressive supranuclear palsy: a phase 2, randomized, placebo-controlled trial.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Dam T
      – PersonEntity:
          Name:
            NameFull: Boxer AL
      – PersonEntity:
          Name:
            NameFull: Golbe LI
      – PersonEntity:
          Name:
            NameFull: Höglinger GU
      – PersonEntity:
          Name:
            NameFull: Morris HR
      – PersonEntity:
          Name:
            NameFull: Litvan I
      – PersonEntity:
          Name:
            NameFull: Lang AE
      – PersonEntity:
          Name:
            NameFull: Corvol JC
      – PersonEntity:
          Name:
            NameFull: Aiba I
      – PersonEntity:
          Name:
            NameFull: Grundman M
      – PersonEntity:
          Name:
            NameFull: Yang L
      – PersonEntity:
          Name:
            NameFull: Tidemann-Miller B
      – PersonEntity:
          Name:
            NameFull: Kupferman J
      – PersonEntity:
          Name:
            NameFull: Harper K
      – PersonEntity:
          Name:
            NameFull: Kamisoglu K
      – PersonEntity:
          Name:
            NameFull: Wald MJ
      – PersonEntity:
          Name:
            NameFull: Graham DL
      – PersonEntity:
          Name:
            NameFull: Gedney L
      – PersonEntity:
          Name:
            NameFull: O'Gorman J
      – PersonEntity:
          Name:
            NameFull: Haeberlein SB
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 11
              Text: 2023 Nov
              Type: published
              Y: 2023
          Identifiers:
            – Type: issn-electronic
              Value: 1546-170X
          Numbering:
            – Type: volume
              Value: 29
            – Type: issue
              Value: 11
          Titles:
            – TitleFull: Nature medicine
              Type: main
ResultId 1